Cinctive Capital Management’s CG Oncology CGON Stock Holding History

Cinctive Capital Management’s Portfolio CGON Stock Details CGON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$286K	Sell	4,022 -20,995	-84%	-$1.37M	0.01%	388
2026 Q1	$1.69M	Sell	25,017 -12,154	-33%	-$689K	0.11%	218
2025 Q4	$1.54M	Buy	37,171 +4,613	+14%	+$191K	0.08%	237
2025 Q3	$1.31M	Sell	32,558 -52,298	-62%	-$1.52M	0.06%	281
2025 Q2	$2.21M	Buy	84,856 +65,901	+348%	+$1.59M	0.12%	205
2025 Q1	$464K	Sell	18,955 -3,653	-16%	-$103K	0.04%	264
2024 Q4	$648K	Buy	+22,608	New	+$773K	0.03%	306

Other funds holding CGON

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cinctive Capital Management's CGON Position: Q2 2026 in Review

Cinctive Capital Management reduced its CG Oncology (CGON) stake by 84% in Q2 2026, selling an estimated $1.37M and leaving 4,022 shares worth $286K. The position accounts for 0.01% of the portfolio, ranked #388.

Cinctive Capital Management first reported a position in CGON in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.21M in Q2 2025. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

Cinctive Capital Management held 4,022 shares of CG Oncology worth $286K as of Q2 2026.
Cinctive Capital Management sold 20,995 CG Oncology shares in Q2 2026, an estimated $1.37M.
CG Oncology made up 0.01% of Cinctive Capital Management's portfolio in Q2 2026, its #388 holding.
Cinctive Capital Management first reported a position in CG Oncology in Q4 2024 and has held it in 7 quarters since.
Cinctive Capital Management's CG Oncology position peaked at $2.21M in Q2 2025.
227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Cinctive Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.